We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+6.53%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$763M
AUM Growth
-$3.93M
Cap. Flow
-$48.2M
Cap. Flow %
-6.31%
Top 10 Hldgs %
34.53%
Holding
214
New
2
Increased
36
Reduced
121
Closed
12

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$3.26M
2
BIIB icon
Biogen
BIIB
+$1.95M
3
GILD icon
Gilead Sciences
GILD
+$1.5M
4
XLNX
Xilinx Inc
XLNX
+$1.24M
5
CELG
Celgene Corp
CELG
+$1.18M

Sector Composition

Rank Sector Weight
1 Healthcare 26.83%
2 Technology 20.54%
3 Industrials 14.4%
4 Financials 9.98%
5 Communication Services 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTV icon
26
Fortive
FTV
$18.6B
$9.67M 1.27%
211,877
-14,645
-6% -$671K
MSFT icon
27
Microsoft
MSFT
$3.71T
$9.47M 1.24%
110,719
+88
+0.1% +$7.22K
FISV
28
Fiserv Inc
FISV
$27.9B
$9.31M 1.22%
142,080
+15,194
+12% +$981K
WM icon
29
Waste Management
WM
$91B
$9.25M 1.21%
107,218
-130
-0.1% -$10.6K
GOOG icon
30
Alphabet (Google) Class C
GOOG
$4.32T
$9.12M 1.2%
174,300
-40,620
-19% -$2.07M
UL icon
31
Unilever
UL
$136B
$7.07M 0.93%
113,553
+2,295
+2% +$145K
NXPI icon
32
NXP Semiconductors
NXPI
$60.4B
$6.98M 0.91%
59,614
-2,180
-4% -$252K
IBM icon
33
IBM
IBM
$224B
$6.69M 0.88%
45,637
-8,572
-16% -$1.25M
HOLX
34
DELISTED
Hologic
HOLX
$6M 0.79%
140,336
-41,788
-23% -$1.67M
MMM icon
35
3M
MMM
$94.3B
$5.8M 0.76%
29,479
-604
-2% -$116K
SBUX icon
36
Starbucks
SBUX
$120B
$5.78M 0.76%
100,566
+6,005
+6% +$340K
INTC icon
37
Intel
INTC
$513B
$4.92M 0.64%
106,476
-3,061
-3% -$134K
GILD icon
38
Gilead Sciences
GILD
$165B
$4.88M 0.64%
68,079
+19,800
+41% +$1.5M
META icon
39
Meta Platforms (Facebook)
META
$1.51T
$4.38M 0.57%
24,828
+1,005
+4% +$178K
HD icon
40
Home Depot
HD
$355B
$3.98M 0.52%
21,007
-260
-1% -$44.9K
AMZN icon
41
Amazon
AMZN
$2.96T
$3.78M 0.5%
64,660
+2,900
+5% +$160K
ABBV icon
42
AbbVie
ABBV
$435B
$3.78M 0.5%
39,089
-270
-0.7% -$25.4K
NVO
43
Novo Nordisk
NVO
$209B
$3.75M 0.49%
139,884
-30,214
-18% -$768K
XOM icon
44
ExxonMobil
XOM
$634B
$3.75M 0.49%
44,835
-2,796
-6% -$231K
CSCO icon
45
Cisco
CSCO
$479B
$3.5M 0.46%
91,354
-3,368
-4% -$120K
BIIB icon
46
Biogen
BIIB
$30.7B
$3.42M 0.45%
10,750
+6,075
+130% +$1.95M
CELG
47
DELISTED
Celgene Corp
CELG
$3.38M 0.44%
32,389
+10,485
+48% +$1.18M
MCD icon
48
McDonald's
MCD
$195B
$3.36M 0.44%
19,512
-375
-2% -$63K
PEP icon
49
PepsiCo
PEP
$190B
$3.32M 0.44%
27,719
-1,554
-5% -$177K
RTX icon
50
RTX Corp
RTX
$301B
$3.19M 0.42%
39,779
+1,220
+3% +$92.6K

Similar funds

Reynders McVeigh Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Reynders McVeigh Capital Management held 214 positions worth $763M, down 0.51% from $767M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Reynders McVeigh Capital Management withdrew a net $48.2M in Q4 2017, closing 12 positions and reducing 121 holdings. Its most notable exit was Kroger, an estimated $1.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Reynders McVeigh Capital Management opened a new position in DexCom worth $638K.

  • Reynders McVeigh Capital Management's largest Q4 2017 buy was DexCom: 44,460 shares worth $638K.
  • Reynders McVeigh Capital Management added most to Stryker in Q4 2017, an estimated $3.26M increase.
  • Reynders McVeigh Capital Management's biggest Q4 2017 reduction was Johnson Controls International, cutting an estimated $7.52M.
  • Reynders McVeigh Capital Management fully exited Kroger in Q4 2017, selling an estimated $1.85M.
  • Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $763M portfolio in Q4 2017.
  • Reynders McVeigh Capital Management opened 2 new positions and closed 12 in Q4 2017.
  • Reynders McVeigh Capital Management's portfolio value fell 0.51% quarter-over-quarter to $763M.

Based on Reynders McVeigh Capital Management's 13F filing for Q4 2017, filed 6 Feb 2018.